BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Integrated DNA Technologies Expands Coralville Manufacturing Footprint to Support Growing Global Demand for MRD Solutions

  April 20, 2026

   · 

  5 min read
• Press Releases

  Allurion Treats First Commercial Patients in the United States, Marking Major Milestone

  April 20, 2026

   · 

  4 min read
• Press Releases

  Following Oral Presentation of Phase I Data at AACR 2026, Debiopharm Announces FDA Fast Track Designation for Lunresertib in Combination With Zedoresertib for Genomic-Defined Platinum-Resistant Ovarian Cancer

  April 20, 2026

   · 

  3 min read
• 

  Sickle cell disease

  Novo’s late-stage sickle cell win piles pressure on competitors

  Novo Nordisk’s etavopivat elicited a 27% drop in vaso-occlusive crises and 48.7% hemoglobin response after 24 weeks, creating “separation amongst PK class candidates,” Truist analysts said on Monday. Novo plans to seek FDA approval in the back half of 2026.

  April 20, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases

  April 20, 2026

   · 

  3 min read
• Press Releases

  Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations

  April 20, 2026

   · 

  3 min read
• Press Releases

  Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA

  April 20, 2026

   · 

  3 min read
• Press Releases

  Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026

  April 20, 2026

   · 

  9 min read
• Press Releases

  Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond

  April 20, 2026

   · 

  7 min read
• Press Releases

  Oragenics Reports 8 study drug doses in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury

  April 20, 2026

   · 

  6 min read